ERBB2 and breast carcinoma: The most prevalent subtype of breast cancer is characterized by being estrogen receptor (ER) and/or progesterone receptor (PR) positive while lacking human epidermal growth factor receptor 2 (HER2), accounting for approximately 73% of all breast cancers (5).